Evidence map›Paper›PMID 39252965›Full record

ArticleiScience2024

Optimized

Bryan Labra, Kshitij Parag-Sharma, John J Powers, Sonal Srivastava, Joel R Walker, Thomas A Kirkland, Caroline K Brennan, Jennifer A Prescher, Antonio L Amelio

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in iScience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Bryan LabraLineberger Comprehensive Cancer Center, UNC School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Kshitij Parag-SharmaGraduate Curriculum in Cell Biology & Physiology, Biological & Biomedical Sciences Program, UNC School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
John J PowersDepartment of Tumor Microenvironment and Metastasis, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA.
Sonal SrivastavaDepartment of Tumor Microenvironment and Metastasis, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA.
Joel R WalkerPromega Biosciences, LLC, San Luis Obispo, CA, USA.
Thomas A KirklandPromega Biosciences, LLC, San Luis Obispo, CA, USA.
Caroline K BrennanDepartment of Chemistry, University of California, Irvine, Irvine, CA, USA.
Jennifer A PrescherDepartment of Chemistry, University of California, Irvine, Irvine, CA, USA.
Antonio L AmelioDepartment of Tumor Microenvironment and Metastasis, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA.

Funding

TRANSLATIONAL RESEARCHP30CA076292 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI John L. Cleveland · 1998 to 2026
$93.5M
Role of CRTC1-MAML2 in Salivary Mucoepidermoid Carcinoma PathobiologyR01DE030123 · NIDCR · UNIV OF NORTH CAROLINA CHAPEL HILL · PI AMELIO, ANTONIO LUIGI · 2021 to 2025
$2.5M
NCI NIH HHS P30 CA076292NIDCR NIH HHS R01 DE030123
6 · The paper itself

Abstract

The ability to visualize and track multiple biological processes

Indexed as

Biological sciencesBiological sciences research methodologiesCancerOptical imaging

Identifiers

PMID39252965
PMCPMC11381837

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.